We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$891M
AUM Growth
+$97.8M
Cap. Flow
+$10.2M
Cap. Flow %
1.14%
Top 10 Hldgs %
29.98%
Holding
153
New
7
Increased
75
Reduced
46
Closed
5

Top Buys

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$2.2M
2
PARA
Paramount Global Class B
PARA
+$1.85M
3
PFE icon
Pfizer
PFE
+$1.84M
4
FDX icon
FedEx
FDX
+$1.32M
5
EXP icon
Eagle Materials
EXP
+$1.25M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.75M
2
T icon
AT&T
T
+$1.67M
3
FTNT icon
Fortinet
FTNT
+$1.51M
4
BUD
ANHEUSER BUSCH COS INC
BUD
+$1.33M
5
FICO icon
Fair Isaac
FICO
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Healthcare 16.63%
3 Consumer Discretionary 11.81%
4 Financials 10.81%
5 Communication Services 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WM icon
126
Waste Management
WM
$90.6B
$381K 0.04%
2,285
+251
+12% +$40.4K
VZ icon
127
Verizon
VZ
$195B
$373K 0.04%
7,175
+917
+15% +$47.8K
SCHP icon
128
Schwab US TIPS ETF
SCHP
$16.2B
$359K 0.04%
11,402
+164
+1% +$5.16K
FANG icon
129
Diamondback Energy
FANG
$57.1B
$340K 0.04%
3,151
-25
-0.8% -$2.71K
PM icon
130
Philip Morris
PM
$297B
$336K 0.04%
3,542
-94
-3% -$8.79K
ADBE icon
131
Adobe
ADBE
$99.5B
$330K 0.04%
581
+100
+21% +$62.5K
SCHO icon
132
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$329K 0.04%
12,938
-870
-6% -$22.2K
VWO icon
133
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$328K 0.04%
6,624
+3
+0% +$151
ISRG icon
134
Intuitive Surgical
ISRG
$125B
$323K 0.04%
900
MO icon
135
Altria Group
MO
$114B
$319K 0.04%
6,728
+12
+0.2% +$550
IBM icon
136
IBM
IBM
$211B
$282K 0.03%
2,110
-254
-11% -$31.9K
TEAM icon
137
Atlassian
TEAM
$25.6B
$276K 0.03%
725
STZ icon
138
Constellation Brands
STZ
$22.2B
$263K 0.03%
1,050
-19
-2% -$4.33K
MA icon
139
Mastercard
MA
$502B
$259K 0.03%
721
VGT icon
140
Vanguard Information Technology ETF
VGT
$141B
$252K 0.03%
4,400
+80
+2% +$4.39K
LLY icon
141
Eli Lilly
LLY
$1.02T
$235K 0.03%
+850
New +$215K
SUSA icon
142
iShares ESG Optimized MSCI USA ETF
SUSA
$4.08B
$228K 0.03%
2,150
WPM icon
143
Wheaton Precious Metals
WPM
$49.5B
$225K 0.03%
+5,250
New +$216K
LRCX icon
144
Lam Research
LRCX
$367B
$221K 0.02%
+3,070
New +$192K
CLX icon
145
Clorox
CLX
$11.6B
$219K 0.02%
1,256
+1
+0.1% +$167
PSX icon
146
Phillips 66
PSX
$84.9B
$212K 0.02%
2,926
-150
-5% -$11.3K
MRVL icon
147
Marvell Technology
MRVL
$168B
$201K 0.02%
+2,300
New +$172K
PSEC icon
148
Prospect Capital
PSEC
$1.07B
$101K 0.01%
12,000
FICO icon
149
Fair Isaac
FICO
$24.3B
-2,636
Closed -$1.05M
GILD icon
150
Gilead Sciences
GILD
$162B
-2,865
Closed -$200K

Similar funds

Callahan Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Callahan Advisors held 153 positions worth $891M, up 12% from $794M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Callahan Advisors's Q4 2021 filing shows 7 new, 75 increased, 46 reduced and 5 closed positions. Its largest new stake was Paramount Global Class B: 53,775 shares worth $1.62M. The largest sale was Bristol-Myers Squibb, an estimated $1.75M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Callahan Advisors's largest Q4 2021 buy was Paramount Global Class B: 53,775 shares worth $1.62M.
  • Callahan Advisors added most to D.R. Horton in Q4 2021, an estimated $2.2M increase.
  • Callahan Advisors's biggest Q4 2021 reduction was Bristol-Myers Squibb, cutting an estimated $1.75M.
  • Callahan Advisors fully exited ANHEUSER BUSCH COS INC in Q4 2021, selling an estimated $1.33M.
  • Callahan Advisors's ten largest holdings make up 30% of its $891M portfolio in Q4 2021.
  • Callahan Advisors opened 7 new positions and closed 5 in Q4 2021.
  • Callahan Advisors's portfolio value rose 12% quarter-over-quarter to $891M.

Based on Callahan Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.